Our study showed that chronic ketamine users carried more genotypic variations of rs6490121 and rs41279104 in the NOS1 gene than the control group and such variations were associated with more negative psychotic symptoms and fewer anxiety symptoms. This evidence concerns the gene NOS1 and Anxiety.